Navigation Links
Vanda Pharmaceuticals to Announce Third Quarter 2010 Financial Results on November 3, 2010
Date:10/28/2010

ROCKVILLE, Md., Oct. 28 /PRNewswire-FirstCall/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA), a biopharmaceutical company focused on the development and commercialization of products for central nervous system disorders, today announced it will release results for the third quarter of 2010, on Wednesday, November 3, 2010, before the market opens. A full text copy of the release will be disseminated at that time.

Mihael H. Polymeropoulos, M.D., President and Chief Executive Officer, will host a conference call to discuss the results at 10:00 AM ET on Wednesday, November 3, 2010.  To participate in the conference call, dial the appropriate number below shortly before the 10:00 AM start time and ask for the Vanda Pharmaceuticals conference call hosted by Dr. Polymeropoulos.The teleconference dial-in numbers are as follows:Domestic callers 1-866-730-5768International callers 1-857-350-1592Participant Passcode 11659354The conference call will be broadcast simultaneously and archived on the Company's website, www.vandapharma.com. Investors should go to the website at least 15 minutes early to register, download, and install any necessary audio software.

A replay of the call will be available on Wednesday, November 3, 2010, beginning at 1:00 PM ET and will be accessible until Wednesday, November 10, 2010, at 5:00 PM ET. The replay call-in number is 1-888-286-8010 for domestic callers and 1-617-801-6888 for international callers. The access number is 14475834.

ABOUT VANDA PHARMACEUTICALS INC.:Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of products for central nervous system disorders.  For more on Vanda Pharmaceuticals Inc., please visit http://www.vandapharma.com.

CONTACT: Cristina Murphy, Communi
'/>"/>

SOURCE Vanda Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Vanda Pharmaceuticals Initiates Phase III Clinical Study Aimed at Resetting the Body Clock
2. Vanda Pharmaceuticals Adds Former U.S. Surgeon General, Steven Galson, to its Board of Directors
3. Vanda Pharmaceuticals Announces Date of Annual Meeting of Stockholders
4. Vanda Pharmaceuticals Announces U.S. Patent Allowance for a Long-Acting Injectable Formulation of Fanapt(TM) (iloperidone) in the U.S.
5. Vanda Pharmaceuticals Announces Expiration of Hart-Scott -Rodino Waiting Period for Exclusive License of Fanapt(TM)
6. Vanda Pharmaceuticals Enters into an Exclusive License Agreement for the Commercialization and Development of Fanapt(TM) in the U.S. and Canada for the Treatment of Schizophrenia
7. FDA Approves Vanda Pharmaceuticals Fanapt(TM) for the Treatment of Schizophrenia
8. Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet
9. Vanda Pharmaceuticals Provides Update on Iloperidone
10. Phase III Data Show Vanda Pharmaceuticals Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia
11. Vanda Presents Phase III Iloperidone Efficacy Data
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... May 21, 2013 Hurel Corporation ("Hurel"), a ... cell-based assay platforms, today announced the appointment of ... the Company,s Board of Directors. Dr. MacDonald is the ... Schering-Plough Research Institute ("SPRI"), which was the pharmaceutical development ... Merck & Co. in 2009. Over a ...
(Date:5/21/2013)... BioElectronics Corp. (PINKSHEETS: BIEL), the maker ... that CEO, Andrew J. Whelan ... Advisory Committee, Orthopedic and Rehabilitation Panel compelling arguments ... counter sales. "It,s been 37 years ... schema," Whelan said.  "While the old classification of ...
(Date:5/21/2013)...   Accuray Incorporated (Nasdaq: ... results involving hundreds of prostate cancer patients treated ... widely used form of prostate stereotactic body radiation ... a median of 5 years, and many to ... of patients with low-risk and 90.7% of patients ...
Breaking Medicine Technology:Hurel Corporation Appoints Leading Pharmaceutical Executive and Toxicologist Dr. James S. MacDonald to Board of Directors 2BioElectronics Presents FDA Reclassification Panel 2BioElectronics Presents FDA Reclassification Panel 3New Data Validates CyberKnife SBRT for Prostate Cancer Treatment 2New Data Validates CyberKnife SBRT for Prostate Cancer Treatment 3
(Date:5/21/2013)... LEAWOOD, Kan. Primary care practice transformation on ... health care reform efforts aimed at achieving better ... Amid emerging evidence that transformation toward the patient-centered ... today,s health care environment, the U.S. Department of ... and Quality funded 14 studies to learn more ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 Mecklenburg EMS ... will hold a free Community Wellness Fair to educate ... The fair will be held on Wednesday, May 22, 2013 ... City YMCA (8100 Old Mallard Creek Road, Charlotte, NC ... Heart Association and the Mecklenburg County Department of ...
(Date:5/21/2013)... Orsiro stent, which is a novel stent platform ... to the Xience Prime everolimus-eluting stent for the ... at nine months in the results of an ... The BIOFLOW-II substudy used intravascular ultrasound (IVUS) and ... hyperplasia and stent apposition at nine months after ...
(Date:5/21/2013)... Boca Raton, Fla. (PRWEB) May 21, 2013 ... TV program distributed on cable networks and cable channels ... of new episodes on its YouTube channel. The producers ... profiles of companies in the shipping industry, the manufacturing ... program highlights pioneering medical facilities and medical practitioners in ...
(Date:5/21/2013)... 21, 2013 MedMar Healing Center ... benefit Second Harvest Food Bank. Twenty-eight businesses, including MedMar Healing ... the food drive. The goal is to raise food to ... problems facing their families in recent years. , “We ... help those in need,” explains Douglas Chloupek of MedMar Healing ...
Breaking Medicine News(10 mins):Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 2Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 3Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 4Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 5Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 6Health News:Mecklenburg EMS Agency Teams Up with the YMCA of Greater Charlotte and Others to Educate the Public on Health Related Initiatives 2Health News:Biodegradable stent proves non-inferior to drug-eluting stent 2Health News:In View hosted by Larry King Announces New Videos on its YouTube Channel 2Health News:San Jose Cannabis Club Helps Feed Hungry Children with Second Harvest Food Bank 2
... Covance Inc. (NYSE: CVD ) today announced that ... on Wednesday, March 11, 2009 at 1:30 p.m. (ET). ... www.covance.com . In order to register and download ... headquarters in Princeton, New Jersey, is one of the world,s ...
... California, San Diego School of Medicine have identified a key ... to divide and replicate themselves. The rapid generation of ... body,s antibody defense mechanism. However, when B cells grow ... multiple myeloma or, when they grow to attack the wrong ...
... Selects Desktop and Production Messaging Solutions for Significant Savings, ... ... Norcross, GA (PRWEB) March 8, ... (NasdaqCM: ESIC)(easylink.com), a global provider of comprehensive messaging services, ...
... Jacqueline Foreman is pleased to be interviewing Dr. Barry Sears ... Talk Radio on Blogtalkradio at www.blogtalkradio.com/yourmentalhealth on Tuesday, ... Listeners are encouraged to call in with their questions at ... join our live members only chat session. If you miss ...
... as family situations change, study finds , , SATURDAY, March ... spoiling grandchildren, but a new study says they might ... and behavior. , Spending time with grandma ... divorced/separated or stepfamily households, according to the report, published ...
... Church of Scientology,s Freedom Magazine article on psychiatric screening was ... , ... Los Angeles, Ca (PRWEB) March 6, 2009 ... has been recognized by the Religion Communicators Council (RCC) with the ...
Cached Medicine News:Health News:Protein helps immune cells to divide and conquer 2Health News:Email Fax Provider, EasyLink Services, Announces Prominent Bio-Pharma Signing 2Health News:Email Fax Provider, EasyLink Services, Announces Prominent Bio-Pharma Signing 3Health News:Zone Diet Creator Dr. Barry Sears to Talk About Latest Book Toxic Fat: When Good Fat Turns Bad 2Health News:Zone Diet Creator Dr. Barry Sears to Talk About Latest Book Toxic Fat: When Good Fat Turns Bad 3Health News:In Tough Times, Kids May Find Solace With Grandparents 2Health News:Scientology Magazine Earns Religion Communicators Council Award 2
... Synergy T-EP - EMG/EP monitoring systems range ... T2EP, T5EP and T10EP systems. These 2, ... in collaboration with leading practitioners, for ease ... of clinical testing. Synergy T-EP harnesses PC ...
Neuropack Sigma MEB-5500 series evoked potential measuring system is a compact, portable, all-in-one unit....
... MYOHANDY family are probably the most ... SystemPLUS line. Based on last generation ... the ISA 100x EP series with ... EP) , 4 channels (ISA 1004, ...
Sierra II power & efficiency plus. Sierra II report generator with automatic sentence generation creates the one-minute report. Complete 2/4 channel EMG/NCV/EP....
Medicine Products: